Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The losartan intervention for endpoint reduction in hypertension study / Cicala, S; DE SIMONE, Giovanni; Gerdts, E; Dahlöf, B; Lindholm, Lh; Kjeldsen, Se; Devereux, Rb. - In: JOURNAL OF HYPERTENSION. - ISSN 0263-6352. - STAMPA. - 28:6(2010), pp. 1134-1140.

Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The losartan intervention for endpoint reduction in hypertension study

DE SIMONE, GIOVANNI;
2010

2010
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The losartan intervention for endpoint reduction in hypertension study / Cicala, S; DE SIMONE, Giovanni; Gerdts, E; Dahlöf, B; Lindholm, Lh; Kjeldsen, Se; Devereux, Rb. - In: JOURNAL OF HYPERTENSION. - ISSN 0263-6352. - STAMPA. - 28:6(2010), pp. 1134-1140.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/367004
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact